Depta, J. P., Lenzini, P. A., Lanfear, D. E., Wang, T. Y., Spertus, J. A., Bach, R. G., & Cresci, S. (2014). Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction. Pharmacogenomics J.
Citação norma ChicagoDepta, Jeremiah P., Petra A. Lenzini, David E. Lanfear, Tracy Y. Wang, John A. Spertus, Richard G. Bach, and Sharon Cresci. "Clinical Outcomes Associated With Proton Pump Inhibitor Use Among Clopidogrel-treated Patients Within CYP2C19 Genotype Groups Following Acute Myocardial Infarction." Pharmacogenomics J 2014.
Citação norma MLADepta, Jeremiah P., et al. "Clinical Outcomes Associated With Proton Pump Inhibitor Use Among Clopidogrel-treated Patients Within CYP2C19 Genotype Groups Following Acute Myocardial Infarction." Pharmacogenomics J 2014.